title: Are all chimeric antigen receptors created equal?
authors.affiliation: Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Jae H
authors.initials: JH
authors.lastname: Park
authors.affiliation: Memorial Sloan Kettering Cancer Center, New York, NY brentjer@mskcc.org.
authors.forename: Renier J
authors.initials: RJ
authors.lastname: Brentjens
mesh_terms: D018941:Antigens, CD19 / Q000276:immunology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D016393:Lymphoma, B-Cell / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008297:Male; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*; D013601:T-Lymphocytes / Q000637:transplantation*
chemical_list: D018941:Antigens, CD19; D011948:Receptors, Antigen, T-Cell